Disitamab vedotin plus toripalimab in patients with locally advanced or metastatic urothelial carcinoma (RC48-C014): a phase Ib/II dose-escalation and dose-expansion study

Li Zhou, Kun Yang, S. Zhang, Xieqiao Yan, Suming Li, Huayan Xu, Jingyuan Li, Yeqiang Liu, Bo Tang, Z.H. Chi, Lu Si, C-L. Cui, Hongqian Guo, Zhijiang He, Jianming Guo, Xinan Sheng